Direct Corporate Syndication: ₹10 Cr to ₹100 Cr+
Ticket Size: ₹10 Crore – ₹100 Crore+

Health, Hospital & Pharma Infrastructure Finance

Specialized CAPEX & Expansion Debt from ₹10 Cr to ₹100 Cr+ for Healthcare Chains, Medical Colleges & Pharmaceutical Manufacturers

Executive Overview

The healthcare and pharmaceutical sector demands specialized debt structuring with custom moratorium periods, staggered machinery import lines, and cash-flow linked repayments. CreditCares is a recognized market leader in syndicating debt for hospitals, diagnostic imaging networks, and API/formulation drug manufacturing units across Mumbai, Thane, Pune, Kolkata, and Durgapur.

Target Borrower Profiles

  • Multi-specialty, super-specialty hospitals and cancer treatment institutes (50+ to 500+ beds)
  • Pharma formulation plants, Active Pharmaceutical Ingredient (API) manufacturers, and sterile injectables
  • Diagnostic pathology chains, PET-CT / MRI scanning centres seeking high-end machinery lines
  • Medical colleges, nursing institutes, and healthcare technology infrastructure builders
  • Ayurvedic, biotech, and pharmaceutical contract manufacturing organizations (CDMO/CRO)

Underwriting & Eligibility Metrics

Evaluation MetricStandard Requirement
Promoter BackgroundQualified doctors, healthcare entrepreneurs, or established pharmaceutical industrial groups with proven track record
Operational ThresholdExisting hospital with 60%+ average bed occupancy or pharma unit with active commercial batches
Regulatory ApprovalsValid clinical establishment licenses, NABH/NABL accreditation or State Pollution Control / Drug Controller approvals
Viability BenchmarksProjected DSCR >= 1.50x throughout debt tenure; viable techno-economic feasibility (TEV)

Financing Benchmark

Indicative Rate:8.50% – 11.25% p.a.
Maximum Tenor:Up to 12 Years (with 12 to 24 Months moratorium period)
Min – Max Ticket:₹10 Crore – ₹100 Crore+
WhatsApp Advisory Desk

Required Documents

Project & Technical Reports
  • Detailed Project Report (DPR) detailing bed additions, OPD/IPD projections, or pharma batch capacities
  • Techno-Economic Viability (TEV) study conducted by approved empaneled agencies
  • Proforma invoices and quotes for imported medical equipment (MRI, CT, Linac) or cleanroom machinery
  • Architect certificates, civil layout estimates, and building plan sanction approvals
Licenses & Regulatory Clearances
  • Drug Controller General of India (DCGI) / State FDA licenses and WHO-GMP / USFDA inspection history
  • AERB approvals for radiological installations, Bio-Medical Waste authorization, Fire Safety NOC
  • Clinical Establishment Act registrations and local municipal clearances
Financial & Corporate Track Record
  • Past 3 years audited financial records of hospital trust, society, or corporate pharma entity
  • Key doctor / promoter profiles, CVs, net worth statements, and tax clearances
  • Cash flow models detailing operational breakeven and debt-service amortisation